TFC Financial Management’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
Other funds holding XENE
TFC Financial Management's XENE Position: Q3 2026 in Review
TFC Financial Management held its Xenon Pharmaceuticals (XENE) position steady in Q3 2026 at 1 share worth $38. The position accounts for ﹤0.01% of the portfolio, ranked #1006.
TFC Financial Management first reported a position in XENE in Q1 2026 and has held it in 3 quarters since. The position peaked at $61 in Q2 2026. 288 funds tracked by Wall St. Rank hold XENE as of Q3 2026.
- TFC Financial Management held 1 share of Xenon Pharmaceuticals worth $38 as of Q3 2026.
- TFC Financial Management left its Xenon Pharmaceuticals share count unchanged in Q3 2026.
- Xenon Pharmaceuticals made up ﹤0.01% of TFC Financial Management's portfolio in Q3 2026, its #1006 holding.
- TFC Financial Management first reported a position in Xenon Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- TFC Financial Management's Xenon Pharmaceuticals position peaked at $61 in Q2 2026.
- 288 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2026.
Based on TFC Financial Management's 13F filing for Q3 2026, filed 26 Oct 2026.